Skip to content
Back to Guavy Wire
Stocks

P&G Health Re-Appoints Madhavan as Independent Director

Instruments
PG
Share

Procter & Gamble Health Limited has approved the re-appointment of Subramanian Madhavan as an Independent Director, effective November 15, 2026. This decision was made by the company's Board of Directors.

Madhavan brings over 35 years of professional experience to his role, having worked in corporate finance, accountancy, legal practice, and information technology governance. His expertise will continue to be valuable to the company as he takes on this ongoing board oversight position.

More on Stocks

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc